|
About HHT Solutions
HHT Solutions is a non-profit, molecular diagnostic lab dedicated
to research and testing to identify mutations that cause Hereditary Hemmorhagic
Telangiectasia (HHT). The lab seeks to achieve the highest possible test
sensitivity at affordable cost by continual scientific improvements.
The molecular tests used to identify mutations are based
on the research of Drs. Michelle Letarte of The Hospital for Sick
Children and Brenda Gallie of the University Health Network, in Toronto.
The HHT Solutions lab is clinically certified by the
College of American Pathologists (CLIA reg. 99DD990947). Click on these links for our latest CAP certificate and CLIA certification.
|
